TABLE 8

Summary of mean ±S.E. inhibitor potencies for 12 human cytochrome P450 activities in pooled human liver microsomes and recombinant heterologously expressed P450 enzymes


Enzyme

Assay

Inhibitor

IC50
Pooled human liver microsomes
Recombinant heterologously expressed enzyme
μM
CYP1A2 Phenacetin O-deethylase Furafylline 1.76 ± 0.28 1.54 ± 0.16
CYP2A6 Coumarin 7-hydroxylase Tranylcypromine 0.449 ± 0.073 0.895 ± 0.262
CYP2B6 Bupropion hydroxylase PPP 7.74 ± 0.47 2.02 ± 0.19
CYP2C8 Amodiaquine N-deethylase Quercetin 3.06 ± 0.31 3.33 ± 0.20
CYP2C9 Diclofenac 4′-hydroxylase Sulfaphenazole 0.272 ± 0.031 0.169 ± 0.004
CYP2C9 Tolbutamide hydroxylase Sulfaphenazole 0.277 ± 0.023 0.200 ± 0.011
CYP2C19 (S)-Mephenytoin 4′-hydroxylase (+)-N-3-Benzylnirvanol 0.414 ± 0.035 0.161 ± 0.019
CYP2D6 Dextromethorphan O-demethylase Quinidine 0.0579 ± 0.0043 1.78 ± 0.04
CYP2E1 Chlorzoxazone 7-hydroxylase Tranylcypromine 8.94 ± 1.54 17.1 ± 2.8
CYP3A Felodipine dehydrogenase Ketoconazole 0.0163 ± 0.0018 0.166 ± 0.023a
0.374 ± 0.031b
CYP3A Midazolam 1′-hydroxylase Ketoconazole 0.0187 ± 0.0025 0.0619 ± 0.0089a
0.105 ± 0.012b
CYP3A Testosterone 6β-hydroxylase Ketoconazole 0.0261 ± 0.0030 0.0746 ± 0.0204a




0.492 ± 0.178b
  • a Mean ± S.E. for recombinant CYP3A4

  • b Mean ± S.E. for recombinant CYP3A5